tetano
Editor, Senior Moderator
J Clin Microbiol
. 2020 Jul 23;58(8):e01228-20.
doi: 10.1128/JCM.01228-20. Print 2020 Jul 23.
My Experience with SARS-CoV-2, with a Focus on Testing
Peggy A Cotter[SUP] 1 [/SUP]
Affiliations
Abstract
Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) got off to a slow start in the United States. In this commentary, I describe my experience with CoV disease 2019 (COVID-19), with a focus on being tested at the University of North Carolina-Chapel Hill Respiratory Diagnostic Center on its inaugural day.
Keywords: COVID-19; COVID-19 testing; SARS-CoV-2; molecular diagnostics.
. 2020 Jul 23;58(8):e01228-20.
doi: 10.1128/JCM.01228-20. Print 2020 Jul 23.
My Experience with SARS-CoV-2, with a Focus on Testing
Peggy A Cotter[SUP] 1 [/SUP]
Affiliations
- PMID: 32703893
- DOI: 10.1128/JCM.01228-20
Abstract
Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) got off to a slow start in the United States. In this commentary, I describe my experience with CoV disease 2019 (COVID-19), with a focus on being tested at the University of North Carolina-Chapel Hill Respiratory Diagnostic Center on its inaugural day.
Keywords: COVID-19; COVID-19 testing; SARS-CoV-2; molecular diagnostics.